Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4(+) T lymphocytes from placental ischemic rats

作者：Novotny Sarah Richards; Wallace Kedra; Heath Judith; Moseley Janae; Dhillon Pushpinder; Weimer Abram; Wallukat Gerd; Herse Florian; Wenzel Katrin; Martin James N Jr; Dechend Ralf; LaMarca Babbette^*

来源：American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 2012, 302(10): R1197-R1201.

DOI：10.1152/ajpregu.00623.2011

• inflammation
• pregnancy
• renal

Novotny SR, Wallace K, Heath J, Moseley J, Dhillon P, Weimer A, Wallukat G, Herse F, Wenzel K, Martin JN Jr, Dechend R, LaMarca B. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4(+) T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol 302: R1197-R1201, 2012. First published March 28, 2012; doi:10.1152/ajpregu.00623.2011.-Hypertension in rats with chronic placental ischemia (reduced uterine perfusion pressure, RUPP) is associated with elevated inflammatory cytokines, agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) and CD4(+) T cells; all of which are elevated in preclamptic women. Additionally, we have shown that adoptive transfer of RUPP CD4(+) T cells increases blood pressure, inflammatory cytokines, and sFlt-1. The objective of this study was to determine the long-term effects of RUPP CD4(+) T cells on AT1-AA, renal and systemic hemodynamics in pregnant rats. To answer this question CD4(+) T splenocytes were magnetically isolated on day 19 of gestation from control RUPP and normal pregnant (NP) rats and injected into a new group of NP rats at day 13 of gestation. On day 19 of gestation mean arterial pressure (MAP) and renal glomerular filtration rates, GFR) were analyzed and serum collected for AT1-AA analysis. To determine a role for AT1-AA to mediate RUPP CD4(+) T cell-induced blood pressure increases, MAP was analyzed in a second group of rats treated with AT1 receptor blockade losartan (10 mg.kg(-1).day(-1)) and in a third group of rats treated with rituximab, a B cell-depleting agent (250 mg/kg) we have shown previously to decrease AT1-AA production in RUPP rats. MAP increased from 101 +/- 2 mmHg NP to 126 +/- 2 mmHg in RUPP rats (P %26lt; 0.001) and to 123 +/- 1 mmHg in NP rats injected with RUPP CD4(+) T cells (NP %26lt; RUPP CD4(+) T cells) (P %26lt; 0.001). Furthermore, GFR decreased from 2.2 ml/min (n = 7) in NP rats to 1.0 ml/min (n = 5) NP %26lt; RUPP CD4(+) T cell. Circulating AT1-AA increased from 0.22 +/- 0.1 units in NP rats to 13 +/- 0.7 (P %26lt; 0.001) units in NP+RUPP CD4(+) T cell-treated rats but decreased to 8.34 +/- 1 beats/min in NP+RUPP CD4(+) T cells chronically treated with rituximab. Hypertension in NP+RUPP CD4(+) T cell group was attenuated by losartan (102 +/- 4 mmHg) and with B cell depletion (101 +/- 5 mmHg). Therefore, we conclude that one mechanism of hypertension in response to CD4(+) T lymphocytes activated during placental ischemia is via AT1 receptor activation, potentially via AT1-AA during pregnancy.

• 出版日期2012-5